| CARD ID | 1250 | |
| Type of strain | Targeted mutant. | |
| Strain name | C.129-Neu3tm1Myg | |
| Internal Code | BALB/c-Neu3tm1Myg | |
| Submitter | ||
| Submitter affiliation or code | ||
| Stock Type | ||
| Material Transfer Conditions |
Others
|
|
| Production method | in-house breeding | |
| Origin (In-house) | Organization | Miyagi Cancer Center Research Institute, Division of Biochemistry |
| Organization code | Myg | |
| Developer | Taeko Miyagi | |
| Origin (From other organizations) | Organization | |
| Organization code | ||
| Developer | ||
| Year introduced | ||
| Introduced Generation | ||
| Remarks | ||
| Gene symbol | Neu3 |
| Gene name | Neuraminidase3 |
| Allele symbol | Neu3tm1Miy |
| Allele name | targeted mutation 1, Taeko Miyagi |
| MGI | MGI:1355305, |
| Chromosome | 3 , 7 , |
| Gene classification | Targeted or trapped gene(knockout etc.) |
| Method | Electroporation |
| OMIM |
| Disease name, Applicable field | Metabolism, Neurobiology, cancer, Immunology, Physiology |